
The month's biggest moves — from Pfizer and Blackstone's obesity co-funding agreement to Lilly's $3.5B Pennsylvania groundbreaking — answered in plain language.
almost 5 years ago
Keeping Tabs on Quality: The Rise of Digitalalmost 5 years ago
China Invests in Building Biotechalmost 5 years ago
Branding Takes on a New Lookalmost 5 years ago
Addressing Access Burdensalmost 5 years ago
Meeting the Patient—Virtuallyalmost 5 years ago
The Age of Influencealmost 5 years ago
Boosting Immunotherapiesalmost 5 years ago
Pharma’s Psychedelic Experiencealmost 5 years ago
Supply Chain Procurementalmost 5 years ago
Our View on 2022: Pharm Exec’s Annual Industry Outlook





